Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for RenovoRx (RNXT) over the last 2 years, with Q3 2025 value amounting to -$175000.0.

  • RenovoRx's Gains from Investment Securities fell 10643.71% to -$175000.0 in Q3 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year increase of 4108.19%. This contributed to the annual value of $2.8 million for FY2024, which is 26369.39% up from last year.
  • Per RenovoRx's latest filing, its Gains from Investment Securities stood at -$175000.0 for Q3 2025, which was down 10643.71% from $3.7 million recorded in Q2 2025.
  • RenovoRx's Gains from Investment Securities' 5-year high stood at $3.7 million during Q2 2025, with a 5-year trough of -$175000.0 in Q3 2025.